Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03865329 · ClinicalTrials.gov registry record · NA

Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)

A NA study of COPD Exacerbation, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03865329: Completed NA study of COPD Exacerbation, sponsored by Mayo Clinic.

NCT03865329 is a NA study of COPD Exacerbation that has completed, run by Mayo Clinic. The registered enrollment target is 9 participants, below the 46-participant average among 3 other COPD Exacerbation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03865329, a NA study of COPD Exacerbation, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This pilot study will look at investigating barriers, facilitators, adherence and effectiveness of an interactive home-based pulmonary rehabilitation program and health coaching for patients who have recently been hospitalized for a COPD related cause.

Primary Outcome

Percentage of participants to adhere to one balance practice routine per day for 6 out of the 7 days for 12 weeks prescribed via the interactive home-based pulmonary rehabilitation program

Conditions Studied

Interventions

  • BEHAVIORAL Intervention- Home-based Pulmonary Rehabilitation

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2018-01-20
Est. Completion 2019-08-02
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03865329 record still lists

NCT03865329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 46-participant average among 3 other COPD Exacerbation trials with a reported enrollment target (80% lower).

The record links to 1 condition, with COPD Exacerbation appearing as the primary indexed condition, and to 1 intervention - of which Intervention- Home-based Pulmonary Rehabilitation is the first listed.

NCT03865329 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT03865329 about?

NCT03865329 is a clinical study titled "Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)". This pilot study will look at investigating barriers, facilitators, adherence and effectiveness of an interactive home-based pulmonary rehabilitation program and health coaching for patients who have recently been hospitalized for a COPD related cause.

What is the current status of trial NCT03865329?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-01-20. Estimated completion is 2019-08-02.

What conditions does trial NCT03865329 study?

This clinical trial studies the following conditions: COPD Exacerbation.

What interventions are being tested in trial NCT03865329?

The interventions under investigation include: Intervention- Home-based Pulmonary Rehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03865329?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03865329 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD Exacerbation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03865329, the US trial registry maintained by the National Library of Medicine. NCT03865329 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.